Androgen Deprivation Therapy For Prostate Cancer May Be Associated With Increased Risk Of Dementia, Study Suggests.

reports that “reducing testosterone levels with androgen deprivation therapy, or A.D.T., is a common treatment for prostate cancer,” but research published online in JAMA Oncology “has found that it more than doubles the risk of dementia.” STAT (10/13, Love) reports that investigators “looked at medical records from the Stanford University Health System from 1994 to 2013.” They found “9,272 men...with prostate cancer diagnoses, 1,826” of whom “were receiving ADT.” The researchers “excluded men with previous dementia diagnoses, and only included those who had records available for follow-up visits.” http://www.nytimes.com/2016/10/13/well/live/prostate-cancer-treatment-can-raise-dementia-risk.html?_r=0